| Values |
| Studies |
|
| Our study N = 65 | Panya MF et al [9] N = 347 | Endayehu et al [6] N = 270 | |
| Age groupes | n (%) | n (%) | n (%) |
| 0 - 5 | 38 (58.46) | 105 (30) | 36 (13.3) |
| 6- 10 | 13 (20.00) | 155 (45) | 101 (37.4) |
| 11 - 15 | 14 (21.54) | 75 (22) | 133 (49.2) |
| >15 |
| 12 (3) |
|
| Sex | n (%) | n (%) | n (%) |
| Males | 31 (47.7) | 180 (52) | 131 (48.5) |
| Females | 34 (52.30) | 167 (48) | 139 (51.5) |
| Sex-ratio | 0.91 | 1.07 | 0.94 |
| WHO paediatric stage | n (%) | n (%) | n (%) |
| Stage III | 43 (66.15) | 166/294 (94) | 80/196 (78) |
| Skin disorder | n (%) | n (%) | n (%) |
| Infectious dermatosis | 47 (72.30) | 256 (73.77) | 162/196 (82.6) |
| Non infectious dermatosis | 23 (35.38) | 189 (54.46) | 88/196 (44.8) |